American pharmaceutical giant Pfizer’s up to US$7.3 billion acquisition of next-generation weight loss drugs developer Metsera will encourage more research…
Read More »Novo Nordisk
Biotech firm Ascletis Pharma said ASC47, its muscle-preserving weight loss drug candidate, could boost the efficacy of the popular anti-obesity…
Read More »
When Hong Kong office worker W.K. Chan began putting on weight as a teenager, her doctor said it was due…
Read More »
The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle…
Read More »
President Xi Jinping has issued a rare reply to a foreign commerce chamber, hailing bilateral cooperation amid a push to…
Read More »